Novo Nordisk A/S vs Pfizer, Inc. — Stock Comparison
Q·Score Breakdown
6.1
Hold
Overall
6.5
Hold
Quality
Health
Growth
Valuation
Sentiment
NVO
High-quality business with 61% return on equity and 33% profit margins.
⚠ revenue declining 8% year-over-year.
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
Analyst Consensus
HOLD
Target $46.65 (+9.5%)
12 analysts
HOLD
Target $29.00 (+8.4%)
27 analysts
Fundamentals
NVO
PFE
11.8×
Trailing P/E
19.7×
12.4×
Forward P/E
9.5×
33.1%
Profit Margin
12.4%
82.4%
Gross Margin
75.8%
60.7%
ROE
8.9%
-7.6%
Revenue Growth
-1.2%
-4.7%
Earnings Growth
—
0.27
Beta
0.39
—
Price / Book
—
$189.0B
Market Cap
$152.2B
$35 – $81
52-Week Range
$22 – $29
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.